P58 LOW CD38 EXPRESSION BY PLASMA CELLS IN EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA PATIENTS

P58 LOW CD38 EXPRESSION BY PLASMA CELLS IN EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA PATIENTS

Bibliographic Details
Main Authors:	L. Notarfranchi, F. Accardi, B. Dalla Palma, C. Mancini, E. Martella, S. Bonomini, P. Storti, D. Toscani, J. Burroughs, V. Marchica, G. Sammarelli, N. Giuliani
Format:	Article
Language:	English
Published:	Wiley 2023-05-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000936360.21891.75

Similar Items

CD38 expression by plasma cells in extramedullary multiple myeloma
by: Laura Notarfranchi, et al.
Published: (2023-11-01)

The transcriptomic profile of CD138+ cells from patients with early progression from smoldering to active multiple myeloma remains substantially unchanged
by: Paola Storti, et al.
Published: (2019-10-01)

IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts
by: Marina Bolzoni, et al.
Published: (2017-04-01)

Metabolic features of myeloma cells in the context of bone microenvironment: Implication for the pathophysiology and clinic of myeloma bone disease
by: Vincenzo Raimondi, et al.
Published: (2022-10-01)

Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets
by: Jessica Burroughs Garcìa, et al.
Published: (2021-06-01)

Neurofibromatosis type I and multiple myeloma coexistence: A possible link?
by: Fabrizio Accardi, et al.
Published: (2018-04-01)

Identification of <i>PSMB4</i> and <i>PSMD4</i> as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma
by: Jessica Burroughs Garcia, et al.
Published: (2023-08-01)

Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response
by: Paola Storti, et al.
Published: (2022-12-01)

P830: IDENTIFICATION OF NOVEL TARGET GENES CORRELATED WITH 1Q21 AMPLIFICATION IN PATIENTS WITH SMOLDERING MYELOMA AND MULTIPLE MYELOMA
by: Nicolas Thomas Iannozzi, et al.
Published: (2023-08-01)

P850: THE HUMORAL AND CELLULAR RESPONSE TO SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA AND PRE-MALIGNANT MONOCLONAL GAMMOPATHIES: IMPACT OF OMICRON VARIANT
by: P. Storti, et al.
Published: (2022-06-01)

Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects
by: Alberto L. Horenstein, et al.
Published: (2025-02-01)

A personalized molecular approach in multiple myeloma: the possible use of RAF/RAS/MEK/ERK and BCL-2 inhibitors
by: Vincenzo Raimondi, et al.
Published: (2022-08-01)

Incidence of Extramedullary Myeloma in Multiple Myeloma Patients
by: Sinan Demircioğlu, et al.
Published: (2019-07-01)

Characteristics and prognostic value of extramedullary chromosomal abnormalities in extramedullary myeloma
by: Yuan Xia, et al.
Published: (2022-10-01)

Extramedullary involvement in multiple myeloma
by: Joan Bladé, et al.
Published: (2012-11-01)

The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells
by: Paola Storti, et al.
Published: (2016-03-01)

Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients
by: Vincenzo Raimondi, et al.
Published: (2025-02-01)

Unusual painful pelvic masses: Extramedullary hematopoiesis with extramedullary multiple myeloma
by: Jennifer Cai, et al.
Published: (2024-05-01)

Advances in the treatment of extramedullary disease in multiple myeloma
by: Yating Li, et al.
Published: (2022-08-01)

Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?
by: Torben Plesner, et al.
Published: (2020-02-01)

Multiple myeloma with extramedullary plasmacytoma: pathogenesis and clinical case
by: M. V. Firsova, et al.
Published: (2022-11-01)

Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucel
by: Saurabh Zanwar, et al.
Published: (2024-06-01)

Relapsed multiple myeloma with gastric and pancreatic extramedullary plasmacytomas
by: Hong Han Lin, et al.
Published: (2023-04-01)

Secondary Extramedullary Myeloma of the Gallbladder: A Case Report
by: Sandhya Kolagatla MD, et al.
Published: (2022-08-01)

Anti CD38 monoclonal antibodies for multiple myeloma treatment
by: Alessandro Gozzetti, et al.
Published: (2022-11-01)

Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma
by: Ilaria Saltarella, et al.
Published: (2020-01-01)

Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse
by: Ludek Pour, et al.
Published: (2014-02-01)

Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model
by: Beatrice Anna Zannetti, et al.
Published: (2020-12-01)

A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis
by: Fabrizio Accardi, et al.
Published: (2018-01-01)

Extramedullary Myeloma to the Liver Following Bispecific Antigen T-Cell Treatment for Refractory Multiple Myeloma
by: Joelle St-Pierre, et al.
Published: (2022-01-01)

Identification of clinical‐biological features of newly diagnosed early relapse multiple myeloma patients eligible for autologous stem cell transplantation
by: Lorenzo Cillo, et al.
Published: (2024-08-01)

Whole genome sequencing and the genetics of extramedullary disease in multiple myeloma
by: Nicholas Bingham, et al.
Published: (2025-01-01)

Relapse of Multiple Myeloma Presenting as Extramedullary Plasmacytomas in Multiple Organs
by: Murat Köse, et al.
Published: (2015-01-01)

Phenomenon of tumor flare with talquetamab in a patient with extramedullary myeloma
by: Mark Forsberg, et al.
Published: (2024-02-01)

Extramedullary Plasmacytoma of the Maxillary Sinuses in a Patient With Multiple Myeloma
by: Caleb Boehler, et al.
Published: (2024-04-01)

PB1974: MULTIVARIATE SPECTRAL BIOTYPING OF EXTRAMEDULLARY MULTIPLE MYELOMA
by: M. Vlachová, et al.
Published: (2022-06-01)

Gastric involvement: A rare extramedullary location of multiple myeloma
by: Cláudia Pedrosa, et al.
Published: (2020-11-01)

Extramedullary disease in multiple myeloma: a systematic literature review
by: Joan Bladé, et al.
Published: (2022-03-01)

A prognostic model for patients with primary extramedullary multiple myeloma
by: Limei Zhang, et al.
Published: (2022-11-01)

Chromothripsis 18 in multiple myeloma patient with rapid extramedullary relapse
by: Jan Smetana, et al.
Published: (2018-01-01)